#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Waldenstrom's macroglobulinaemia refractory Indolent systemic mastocytosis ROHHAD syndrome IPEX syndrome Leukocyte adhesion deficiency type I Epileptic encephalopathy Myasthenia gravis Retinopathy proliferative Glomerulonephritis membranoproliferative Oesophageal adenocarcinoma stage III Glioblastoma multiforme Primary mediastinal large B-cell lymphoma Chronic myelomonocytic leukaemia Small cell lung cancer limited stage Pyruvate dehydrogenase complex deficiency More trials…

Learn about Rare Diseases

Hereditary angioedema – Trials in Disease Sarcoma – Basic Information Wolfram syndrome – Basic Information Paroxysmal nocturnal haemoglobinuria – Life with Disease Erdheim-Chester disease – Diagnostics Medulloblastoma Hepatoblastoma – Life with Disease Familial amyotrophic lateral sclerosis Haemophilia B without inhibitors – Treatment Idiopathic inflammatory myopathy – Treatment More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Lanreotide Vusolimogene Oderparepvec ABBV-8736 Semaglutide Teriflunomide Tildacerfont Flecainide Acetate Seladelpar Alendronic Acid Vonicog Alfa Tremelimumab Avacincaptad Pegol GS-1720 Parsaclisib Hydrochloride Dasiglucagon Evolocumab Sar444656 Ace Inhibitors, Plain Zanidatamab Collagenase More therapies…

Learn about Your Condition

Poor quality sleep Lymphoma Oesophageal carcinoma Cardiac failure acute Lung cancer metastatic Ventricular fibrillation Pulmonary alveolar haemorrhage Tendon injury Head and neck cancer stage III Gastrointestinal melanoma Myofascial pain syndrome Retinal vein occlusion Organ donor Rabies Ocular lymphoma More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe

🇦🇹 Austria

🇭🇷 Croatia

🇨🇿 Czech Republic

🇩🇰 Denmark

🇪🇪 Estonia

🇫🇮 Finland

🇫🇷 France

🇩🇪 Germany

🇮🇸 Iceland

🇮🇹 Italy

🇱🇻 Latvia

🇱🇹 Lithuania

🇳🇱 Netherlands

🇳🇴 Norway

🇵🇱 Poland

🇵🇹 Portugal

🇷🇴 Romania

🇸🇰 Slovakia

🇸🇮 Slovenia

🇪🇸 Spain

🇸🇪 Sweden

Epidermolysis bullosa

Study on ABCB5+ MSCs for Recessive Dystrophic and Junctional Epidermolysis Bullosa Patients

Not yet recruiting

3 1 1
Investigated Diseases:
- Epidermolysis bullosa
Investigated Drugs:
+6
Study on Rigosertib Sodium for Patients with Recessive Dystrophic Epidermolysis Bullosa and Advanced Squamous Cell Carcinoma

Not recruiting

2 1 1
Investigated Diseases:
- Epidermolysis bullosa
Investigated Drugs:
- Rigosertib Sodium
Study on the Safety of Allogeneic Adipose Tissue-Derived Mesenchymal Stromal Cells for Patients with Epidermolysis Bullosa

Not recruiting

1 1 1
Investigated Diseases:
- Epidermolysis bullosa
Investigated Drugs:
- Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells Expanded

1 2

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Epidermolysis bullosa

Study on ABCB5+ MSCs for Recessive Dystrophic and Junctional Epidermolysis Bullosa Patients

Study on Rigosertib Sodium for Patients with Recessive Dystrophic Epidermolysis Bullosa and Advanced Squamous Cell Carcinoma

Study on the Safety of Allogeneic Adipose Tissue-Derived Mesenchymal Stromal Cells for Patients with Epidermolysis Bullosa

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies